Phase II trial of concurrent carboplatin, docetaxel and intensity modulated radiation therapy (IMRT) for patients with unresectable stage III non-small cell lung cancer
Phase of Trial: Phase II
Latest Information Update: 27 Jul 2007
At a glance
- Drugs Carboplatin; Docetaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 27 Jul 2007 New trial record.